This inventor holds 4 USPTO granted patents. Top assignees: Astra Aktiebolag, Astrazeneca Ab. Active years: 2001-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2006
Title: Gordon Santesson: Innovator in Pharmaceutical Formulations
Introduction
Gordon Santesson is a notable inventor based in Hörby, Sweden. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of metered dose inhalers. With a total of 4 patents to his name, Santesson's work has had a meaningful impact on the treatment of respiratory conditions.
Latest Patents
Among his latest patents, Santesson has disclosed a formulation for a new metered unit dose comprising 40 µg or less of budesonide. This formulation is designed for the treatment of conditions affecting the nose. His innovative approach aims to improve the efficacy and delivery of medication for patients suffering from nasal ailments.
Career Highlights
Throughout his career, Santesson has worked with prominent companies in the pharmaceutical industry, including Astra Aktiebolag and AstraZeneca AB. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in drug formulation.
Collaborations
Santesson has collaborated with several professionals in his field, including Hans Nilsson and Karin Malmqvist-Granlund. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Gordon Santesson's contributions to pharmaceutical formulations highlight his dedication to improving patient care through innovative solutions. His work continues to influence the industry and pave the way for future advancements in medication delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile